Raltegravir in HIV-Exposed Neonates Raltegravir in HIV-Exposed Neonates

This study provides insight into the pharmacokinetics and safety of raltegravir in HIV-exposed neonates and discusses optimal dosing regimens.JAIDS: Journal of Acquired Immune Deficiency Syndromes
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news